https://orcid.org/0000-0003-1299-9299
References
- ICH (2019), “ICH Harmonised Guideline E9 (R1): Addendum on Estimands and Sensitivity Analysis in Clinical Trials,” ICH.
- Olkin, I., Sacks, J., Blumstein, A., Eddy, A., Jurs, P., Kruskal, W., Kurtz, T., McDonald, G. C., Peierls, R., Shaman, P., and Spurgeon, W. (1990), “Cross-disciplinary Research in the Statistical Sciences,” Statistical Science, 121–146.
- Van Lancker, K., Tarima, S., Bartlett, J., Bauer, M., Bharani-Dharan, B., Bretz, F., Flournoy, N., Michiels, H., Olarte Parra, C., Rosenberger, J. L., et al. (2023), “Estimands and Their Estimators for Clinical Trials Impacted by the Covid-19 Pandemic: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions,” Statistics in Biopharmaceutical Research, 1–12.